Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2009 2
2010 2
2011 1
2014 1
2017 1
2023 1
2024 3
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Erratum zu: CRIMSON.
Lorenz K, Peters T, Holz FG; DOG AG Klinische Studienzentren. Lorenz K, et al. Ophthalmologie. 2026 Feb;123(Suppl 1):68. doi: 10.1007/s00347-025-02373-w. Ophthalmologie. 2026. PMID: 41498924 German. No abstract available.
Asymmetric scapuloperoneal phenotype of MATR3-related distal myopathy: case series.
Murtazina A, Subbotin D, Kuchina A, Gilvanova O, Degterev D, Shchagina O, Cherevatova T, Bulakh M, Sherstyukova D, Ryzhkova O, Kurushina O, Skoblov M, Borovikov A, Kutsev S. Murtazina A, et al. Among authors: subbotin d. Front Genet. 2024 Aug 13;15:1414928. doi: 10.3389/fgene.2024.1414928. eCollection 2024. Front Genet. 2024. PMID: 39192891 Free PMC article.
Unexpected SLC34A3 rickets in a case of suspected distal myopathy.
Sharova M, Subbotin D, Murtazina A, Zabudskaya K, Ryzhkova O, Dadali E. Sharova M, et al. Among authors: subbotin d. Pediatr Nephrol. 2025 Dec;40(12):3647-3649. doi: 10.1007/s00467-025-06906-y. Epub 2025 Jul 22. Pediatr Nephrol. 2025. PMID: 40694099
[CRIMSON : A multicentre randomised, sham-controlled, double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy].
Lorenz K, Peters T, Holz FG; DOG AG Klinische Studienzentren. Lorenz K, et al. Ophthalmologie. 2026 Feb;123(2):123-127. doi: 10.1007/s00347-025-02345-0. Epub 2025 Nov 20. Ophthalmologie. 2026. PMID: 41263999 German. No abstract available.
18 results